| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |